A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion

J Biol Chem. 2001 Jun 29;276(26):23667-73. doi: 10.1074/jbc.M103023200. Epub 2001 Apr 25.

Abstract

The hormone glucose-dependent insulinotropic polypeptide (GIP) is an important regulator of insulin secretion. GIP has been shown to increase adenylyl cyclase activity, elevate intracellular Ca(2+) levels, and stimulate a mitogen-activated protein kinase pathway in the pancreatic beta-cell. In the current study we demonstrate a role for arachidonic acid in GIP-mediated signal transduction. Static incubations revealed that both GIP (100 nm) and ATP (5 microm) significantly increased [(3)H]arachidonic acid ([(3)H]AA) efflux from transfected Chinese hamster ovary K1 cells expressing the GIP receptor (basal, 128 +/- 11 cpm/well; GIP, 212 +/- 32 cpm/well; ATP, 263 +/- 35 cpm/well; n = 4; p < 0.05). In addition, GIP receptors were shown for the first time to be capable of functionally coupling to AA production through Gbetagamma dimers in Chinese hamster ovary K1 cells. In a beta-cell model (betaTC-3), GIP was found to elicit [(3)H]AA release, independent of glucose, in a concentration-dependent manner (EC(50) value of 1.4 +/- 0.62 nm; n = 3). Although GIP did not potentiate insulin release under extracellular Ca(2+)-free conditions, it was still capable of elevating intracellular cAMP and stimulating [(3)H]AA release. Our data suggest that cAMP is the proximal signaling intermediate responsible for GIP-stimulated AA release. Finally, stimulation of GIP-mediated AA production was shown to be mediated via a Ca(2+)-independent phospholipase A(2). Arachidonic acid is therefore a new component of GIP-mediated signal transduction in the beta-cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism
  • Arachidonic Acid / pharmacology
  • CHO Cells
  • Calcium / metabolism
  • Cell Line
  • Cricetinae
  • Cyclic AMP / biosynthesis
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • GTP-Binding Protein beta Subunits*
  • GTP-Binding Protein gamma Subunits*
  • Gastric Inhibitory Polypeptide / pharmacology*
  • Glucose / pharmacology
  • Heterotrimeric GTP-Binding Proteins / antagonists & inhibitors
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Isoquinolines / pharmacology
  • Peptide Fragments / genetics
  • Phospholipases A / physiology*
  • Phospholipases A2
  • Receptors, Gastrointestinal Hormone / genetics
  • Receptors, Gastrointestinal Hormone / metabolism*
  • Recombinant Proteins*
  • Signal Transduction*
  • Sulfonamides*
  • Transfection

Substances

  • Enzyme Inhibitors
  • G-protein Beta gamma
  • GTP-Binding Protein beta Subunits
  • GTP-Binding Protein gamma Subunits
  • Insulin
  • Isoquinolines
  • Peptide Fragments
  • Receptors, Gastrointestinal Hormone
  • Recombinant Proteins
  • Sulfonamides
  • Arachidonic Acid
  • Gastric Inhibitory Polypeptide
  • gastric inhibitory polypeptide receptor
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • BARKct protein, recombinant
  • Phospholipases A
  • Phospholipases A2
  • Heterotrimeric GTP-Binding Proteins
  • Glucose
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Calcium